Centocor, Eli Lilly deal

CNTO and Lilly amended their sales and distribution agreement, under which Lilly no longer will have the exclusive right to buy ReoPro for resale in Japan. The anti-platelet antibody is sold in the U.S. for use in high-risk angioplasty. Lilly received 920,716 CNTO shares in exchange for the rights, and now owns 1.6 million (2 percent) of CNTO’s shares outstanding. ...